Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Catecholamines Market
The growing geriatric population represents a significant growth driver for the catecholamines market. As the global population ages, the incidence of age-related health conditions and chronic diseases increases. For instance, according to the Public Library of Science (PLOS) report, about 21% of the elderly in India reportedly have at least one chronic disease. The report also stated that, 17% elderly in rural areas and 29% in urban areas suffer from a chronic disease. Hypertension and diabetes account for about 68% of all chronic diseases. Therefore, catecholamines, with their ability to rapidly improve hemodynamic parameters, are poised to be a foundation in the management of acute exacerbations and complications arising from chronic conditions. Such aforementioned factor is anticipated to boost the market growth.